Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL) -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (294)	2/4/2006 4:26:01 PM
From: tuck	Read Replies (2) \| Respond to of 566

[The novel Syk inhibitor R406 blocks JNK-mediated gene expression in synoviocytes] >>J Pharmacol Exp Ther. 2006 Feb 1; [Epub ahead of print] The novel Syk inhibitor R406 blocks JNK-mediated gene expression in synoviocytes. Cha HS, Boyle DL, Inoue T, Schoot R, Tak PP, Pine P, Firestein GS. University of California - San Diego. Spleen tyrosine kinase (Syk) is a key regulator of cell signaling induced by cytokines or Fc receptors engagement. However the role of Syk in rheumatoid arthritis (RA) is not known yet. We investigated the pathways activated by Syk in tumor necrosis factor-alpha (TNFalpha)-stimulated RA fibroblast-like synoviocytes (FLS) using the novel Syk inhibitor, R406. On immunohistochemistry, Syk was detected in RA synovial tissue (ST), primarily in the synovial intimal lining. Western blot analysis demonstrated significantly greater amounts of phospho-Syk expression in RA ST compared with osteoarthritis ST. The kinase was expressed and functionally activated by TNFalpha in FLS and was blocked by R406. Western blot analysis demonstrated that Syk inhibition by R406 markedly suppressed TNFalpha-induced c-Jun N-terminal kinase (JNK) phosphorylation in FLS, with a modest decrease in extracellular signal-regulated kinase (ERK) phosphorylation. Surprisingly, p38 activation was not affected by R406. The Syk inhibitor also decreased TNFalpha-induced mitogen-activated protein kinase kinase (MKK) 4 phosphorylation but not MKK3 and MKK6 phosphorylation, which is consistent with its selective sparing of p38. The connection between Syk and JNK was confirmed by demonstrating decreased phospho-c-Jun protein expression and complete inhibition of JNK function in R406- treated cells. R406 also suppressed downstream actions of JNK as determined by activator protein 1 (AP-1) binding as well as matrix metalloproteinase (MMP)-3 gene expression. These data demonstrate that Syk activation plays an essential role in TNFalpha-induced cytokine and MMP production in RA FLS, especially by suppressing activation of the JNK pathway.<< Full text freebie, hot off the press: jpet.aspetjournals.org Cheers, Tuck